$STRO

“- $STRO $BMY $GMAB $ABBV $ESAIY - Sutro reads the farletuzumab tea leaves - oncologypipeline.com/apexonc…”

“Why termination of $BMY 's $ESALY folate receptor ADC deal could spell bad news for $STRO , via @ApexOnco -> oncologypipeline.com/apexonc… $ABBV $GMAB”

“As of today, $STRO market is $250M while has $313M in cash and no debt! 2 phase III and 4 phase II and 3 phase I trials! This company is on sale!”

“$STRO . Biotech with over $6/share in cash trading under $4. Prospects for the drug are good. Lots of very smart biotech investors onboard. Company has plenty of money to get through phase 3 on its ovarian cancer drug. The company has licensing deals with $PCVX , $MRK , and Astellas. $PCVX is a $6B ”

“$MRSN $STRO Article highlights potential for iADC… biospace.com/article/drug-de…”

“Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer. For more info, ir.sutrobio.com/news-events/… #SutroBio #BiotechNews $STRO”

“$STRO I have some lines but never played before looking through my P&L. In a minor reversal now and I think I can take it to 3.93 and scale out then wait for the closer over that bigger downtrend before adding it back for the big move to 5. Will do half size in this too”